Showing results (1691-1700 of 1,743) with videos related to

Sort By:
Pageof 175
Blood|October 28, 2017
Ruxolitinib vs best available therapy for ET intolerant or resistant to hydroxycarbamideClaire N Harrison, Adam J Mead, Anesh Panchal, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 14, 2010
Stable synthetic bacteriochlorins overcome the resistance of melanoma to photodynamic therapyPawel Mroz, Ying-Ying Huang, Angelika Szokalska, et al.
Bioorganic & Medicinal Chemistry Letters|June 10, 2008
Pyrazolopyridines as a novel structural class of potent and selective PDE4 inhibitorsJ Nicole Hamblin, Tony D R Angell, Stuart P Ballantine, et al.
Hematological Oncology|August 7, 2019
A phase II study to assess the safety and efficacy of the dual mTORC1/2 inhibitor vistusertib in relapsed, refractory DLBCLToby A Eyre, Catherine Hildyard, Angela Hamblin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2017
Outcome of Azacitidine Therapy in Acute Myeloid Leukemia Is not Improved by Concurrent Vorinostat Therapy but Is Predicted by a Diagnostic Molecular SignatureCharles F Craddock, Aimee E Houlton, Lynn Swun Quek, et al.
Plos One|June 23, 2011
The relationship between population structure and aluminum tolerance in cultivated sorghumFernanda F Caniato, Claudia T Guimarães, Martha Hamblin, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 21, 2020
Chemical mutagenesis of a GPCR ligand: Detoxifying "inflammo-attraction" to direct therapeutic stem cell migrationJean-Pyo Lee, Runquan Zhang, Maocai Yan, et al.
Carbohydrate Polymers|August 23, 2021
Hyaluronic acid-based nanoplatforms for Doxorubicin: A review of stimuli-responsive carriers, co-delivery and resistance suppressionMilad Ashrafizadeh, Sepideh Mirzaei, Mohammad Hossein Gholami, et al.
BMC Genomics|November 20, 2016
Pooled genome wide association detects association upstream of FCRL3 with Graves' diseaseJwu Jin Khong, Kathryn P Burdon, Yi Lu, et al.
The Lancet. Diabetes & Endocrinology|July 5, 2022
Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma: a retrospective, multicentre, cohort study of 3679 patients with long-term imaging surveillanceRoss Hamblin, Ashley Vardon, Josephine Akpalu, et al.
Pageof 175